EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MM-129 Counteracts 5-Fluorouracil-Induced Cellular Senescence in Colon Cancer via SIRT1/STAT3 Signaling Pathway

Hubert Klepacki iD, Beata Sieklucka, Joanna Kalafut iD, Krystyna Kowalczuk iD, Arkadiusz Surazynski iD, Mariusz Mojzych iD, Anna Pryczynicz iD, Dariusz Pawlak iD, Natascia Tiso iD, Justyna Magdalena Hermanowicz iD

Cells · 24.09.2025 · 14 (19) · 1498

DOI: 10.3390/cells14191498 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 24.09.2025. Verfasst von Hubert Klepacki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacodynamics, Medical University of Bialystok, Mickiewicza 2C, 15-222 Bialystok, Poland. Hauptthemen laut MEDLINE: Cellular Senescence, Fluorouracil, Colonic Neoplasms, STAT3 Transcription Factor. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Bialystok, Medical University of Bialystok, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular senescence plays a critical role in tumorigenesis and is recognized as a hallmark of colorectal cancer (CRC). Emerging evidence suggests that 5-fluorouracil (5-FU)-induced senescence may contribute to chemoresistance and tumor recurrence. Here, we investigated the effect of 5-FU on colon cancer cell senescence and whether MM-129 (pyrazolo[4,3-e]tetrazolo[4,5-b][1,2,4]triazine sulfonamide) can antagonize this activity. Senescence was identified by the expression of senescence-associated β-galactosidase (SA-β-gal) and cyclin-dependent kinase inhibitor 1A (p21) using qPCR, microscopy, flow cytometry, and immunohistochemistry. We also measured interleukin 6 (IL-6) and tumor necrosis factor (TNF-α) as key SASP cytokines, along with E-cadherin (CDH1), a marker of epithelial integrity. The SIRT1/STAT3 pathway was evaluated to elucidate the mechanism of MM-129′s action. MM-129 counteracted 5-FU-induced senescence in colon cancer models, reducing p21 levels in zebrafish xenografts and the number of SA-β-gal-positive cells in vitro and in tumor tissues from DLD-1 and HT-29 mouse xenografts. MM-129 also inhibited senescence-associated responses by suppressing SASP cytokines (IL-6, TNF-α) and restoring E-cadherin (CDH1), and it modulated the SIRT1/STAT3 axis, which may underlie the observed senotherapeutic effects. In conclusion, MM-129 represents a novel senotherapeutic candidate. By modulating the SIRT1/STAT3 axis, it may suppress the SASP and weaken pro-survival signaling, thereby facilitating selective clearance of senescent cells. Integrating senotherapeutics with conventional cancer therapies may enhance efficacy and open new avenues for translational research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceFluorouracilColonic NeoplasmsSTAT3 Transcription FactorSignal TransductionSirtuin 1HumansAnimalsCell Line, TumorZebrafishMiceXenograft Model Antitumor Assays

Stichwörter der Autor:innen

5-fluorouracilMM-129SIRT1/STAT3 signalingcellular senescencechemoresistancecolorectal cancersenescence-associated secretory phenotypesenotherapeutic agent

Substanzen

FluorouracilSTAT3 Transcription FactorSirtuin 1STAT3 protein, humanSIRT1 protein, human

Autor:innen und Institutionen

  • Department of Pharmacodynamics, Medical University of Bialystok, Mickiewicza 2C, 15-222 Bialystok, Poland.
  • Department of Monitored Pharmacotherapy, Medical University of Bialystok, 15-222 Bialystok, Poland.
  • Department of Biochemistry and Molecular Biology, Medical University of Lublin, Chodźki 1, 20-093 Lublin, Poland.
  • Department of Integrated Medical Care, Medical University of Bialystok, Mickiewicza 2C, 15-222 Bialystok, Poland.
  • Department of Medicinal Chemistry, Medical University of Bialystok, Mickiewicza 2C, 15-222 Bialystok, Poland.
  • Faculty of Health Science, Collegium Medicum, The Mazovian Academy in Plock, Plac Dabrowskiego 2, 09-402 Plock, Poland.

ORCID-Profile: Hubert Klepacki, Joanna Kalafut, Krystyna Kowalczuk, Arkadiusz Surazynski, Mariusz Mojzych, Anna Pryczynicz, Dariusz Pawlak, Natascia Tiso, Justyna Magdalena Hermanowicz

Förderung

  • Medical University of Bialystok
  • Medical University of Bialystok, Poland

Zitieren

APA

Klepacki, H., Sieklucka, B., Kalafut, J., Kowalczuk, K., Surazynski, A., Mojzych, M., Pryczynicz, A., Pawlak, D., Tiso, N., & Hermanowicz, J. M. (2025). MM-129 Counteracts 5-Fluorouracil-Induced Cellular Senescence in Colon Cancer via SIRT1/STAT3 Signaling Pathway. Cells, 14(19), 1498. https://doi.org/10.3390/cells14191498

Vancouver

Klepacki H, Sieklucka B, Kalafut J, Kowalczuk K, Surazynski A, Mojzych M, et al. MM-129 Counteracts 5-Fluorouracil-Induced Cellular Senescence in Colon Cancer via SIRT1/STAT3 Signaling Pathway. Cells. 2025;14(19):1498. doi:10.3390/cells14191498

BibTeX
@article{Klepacki2025,
  author = {Klepacki, Hubert and Sieklucka, Beata and Kalafut, Joanna and Kowalczuk, Krystyna and Surazynski, Arkadiusz and Mojzych, Mariusz and Pryczynicz, Anna and Pawlak, Dariusz and Tiso, Natascia and Hermanowicz, Justyna Magdalena},
  title = {MM-129 Counteracts 5-Fluorouracil-Induced Cellular Senescence in Colon Cancer via SIRT1/STAT3 Signaling Pathway},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {19},
  pages = {1498},
  doi = {10.3390/cells14191498}
}
Kostenlos starten →